BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 25573503)

  • 1. Separate and overlapping specificities in rheumatoid arthritis antibodies binding to citrulline- and homocitrulline-containing peptides related to type I and II collagen telopeptides.
    Turunen S; Hannonen P; Koivula MK; Risteli L; Risteli J
    Arthritis Res Ther; 2015 Jan; 17(1):2. PubMed ID: 25573503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ureido group-specific antibodies are induced in rabbits immunized with citrulline- or homocitrulline-containing antigens.
    Turunen S; Koivula MK; Risteli L; Risteli J
    Autoimmunity; 2016 Nov; 49(7):459-465. PubMed ID: 27098309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies binding to citrullinated telopeptides of type I and type II collagens and to mutated citrullinated vimentin synergistically predict the development of seropositive rheumatoid arthritis.
    Koivula MK; Heliövaara M; Rissanen H; Palosuo T; Knekt P; Immonen H; Risteli J
    Ann Rheum Dis; 2012 Oct; 71(10):1666-70. PubMed ID: 22419777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are there autoantibodies reacting against citrullinated peptides derived from type I and type II collagens in patients with rheumatoid arthritis?
    Koivula MK; Aman S; Karjalainen A; Hakala M; Risteli J
    Ann Rheum Dis; 2005 Oct; 64(10):1443-50. PubMed ID: 16162901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Automated immunoassays for the autoantibodies to carbamylated or citrullinated telopeptides of type I and II collagens.
    Häyrynen J; Kärkkäinen M; Kononoff A; Arstila L; Elfving P; Niinisalo H; Savolainen E; Kautiainen H; Risteli J; Kaipiainen-Seppänen O; Koivula MK
    Clin Chem Lab Med; 2015 Aug; 53(9):1375-80. PubMed ID: 25389994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitive immunoassays for the autoantibodies reacting against citrullinated carboxy-terminal telopeptides of type I and type II collagens in patients with rheumatoid arthritis.
    Koivula MK; Ramberg J; Aman S; Karjalainen A; Hakala M; Risteli J
    Clin Chem Lab Med; 2005; 43(12):1400-5. PubMed ID: 16309380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoantibodies binding to citrullinated telopeptide of type II collagen and to cyclic citrullinated peptides predict synergistically the development of seropositive rheumatoid arthritis.
    Koivula MK; Heliövaara M; Ramberg J; Knekt P; Rissanen H; Palosuo T; Risteli J
    Ann Rheum Dis; 2007 Nov; 66(11):1450-5. PubMed ID: 17472989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibodies to several citrullinated antigens are enriched in the joints of rheumatoid arthritis patients.
    Snir O; Widhe M; Hermansson M; von Spee C; Lindberg J; Hensen S; Lundberg K; Engström A; Venables PJ; Toes RE; Holmdahl R; Klareskog L; Malmström V
    Arthritis Rheum; 2010 Jan; 62(1):44-52. PubMed ID: 20039432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relatedness of Antibodies to Peptides Containing Homocitrulline or Citrulline in Patients with Rheumatoid Arthritis.
    Lac P; Racapé M; Barra L; Bell DA; Cairns E
    J Rheumatol; 2018 Mar; 45(3):302-309. PubMed ID: 29196382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of anti-mutated citrullinated vimentin, anti-cyclic citrullinated peptides, anti-glucose-6-phosphate isomerase and anti-keratin antibodies and rheumatoid factor in the diagnosis of rheumatoid arthritis in Chinese patients.
    Zhu T; Feng L
    Int J Rheum Dis; 2013 Apr; 16(2):157-61. PubMed ID: 23773638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical evaluation of anti-mutated citrullinated vimentin by ELISA in rheumatoid arthritis.
    Soós L; Szekanecz Z; Szabó Z; Fekete A; Zeher M; Horváth IF; Dankó K; Kapitány A; Végvári A; Sipka S; Szegedi G; Lakos G
    J Rheumatol; 2007 Aug; 34(8):1658-63. PubMed ID: 17611988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory characteristics of citrullinated telopeptides of type I and II collagens for autoantibody binding in patients with rheumatoid arthritis.
    Koivula MK; Aman S; Alasaarela E; Karjalainen A; Hakala M; Risteli J
    Rheumatology (Oxford); 2006 Nov; 45(11):1364-9. PubMed ID: 16632481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic value of anti-modified citrullinated vimentin in rheumatoid arthritis.
    Maraina CH; Nurdayana AK; Rusni D; Azwany Y
    Int J Rheum Dis; 2010 Oct; 13(4):335-9. PubMed ID: 21199468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple antibody reactivities to citrullinated antigens in sera from patients with rheumatoid arthritis: association with HLA-DRB1 alleles.
    Snir O; Widhe M; von Spee C; Lindberg J; Padyukov L; Lundberg K; Engström A; Venables PJ; Lundeberg J; Holmdahl R; Klareskog L; Malmström V
    Ann Rheum Dis; 2009 May; 68(5):736-43. PubMed ID: 18635594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Significance of citrullinated collagen type II and its antibodies in rheumatoid arthritis].
    Tian X; Bi LQ; Li ZG
    Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(33):2334-8. PubMed ID: 17156630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different amounts of protein-bound citrulline and homocitrulline in foot joint tissues of a patient with anti-citrullinated protein antibody positive erosive rheumatoid arthritis.
    Turunen S; Koivula MK; Melkko J; Alasaarela E; Lehenkari P; Risteli J
    J Transl Med; 2013 Sep; 11():224. PubMed ID: 24060405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antihomocitrullinated fibrinogen antibodies are specific to rheumatoid arthritis and frequently bind citrullinated proteins/peptides.
    Scinocca M; Bell DA; Racapé M; Joseph R; Shaw G; McCormick JK; Gladman DD; Pope J; Barra L; Cairns E
    J Rheumatol; 2014 Feb; 41(2):270-9. PubMed ID: 24429169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-cyclic citrullinated peptide positivity in non-rheumatoid arthritis disease samples: citrulline-dependent or not?
    Vannini A; Cheung K; Fusconi M; Stammen-Vogelzangs J; Drenth JP; Dall'Aglio AC; Bianchi FB; Bakker-Jonges LE; van Venrooij WJ; Pruijn GJ; Zendman AJ
    Ann Rheum Dis; 2007 Apr; 66(4):511-6. PubMed ID: 16984940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disordered Antigens and Epitope Overlap Between Anti-Citrullinated Protein Antibodies and Rheumatoid Factor in Rheumatoid Arthritis.
    Zheng Z; Mergaert AM; Fahmy LM; Bawadekar M; Holmes CL; Ong IM; Bridges AJ; Newton MA; Shelef MA
    Arthritis Rheumatol; 2020 Feb; 72(2):262-272. PubMed ID: 31397047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic value of anti-mutated citrullinated vimentin in comparison to anti-cyclic citrullinated peptide and anti-viral citrullinated peptide 2 antibodies in rheumatoid arthritis: an Italian multicentric study and review of the literature.
    Bartoloni E; Alunno A; Bistoni O; Bizzaro N; Migliorini P; Morozzi G; Doria A; Mathieu A; Lotzniker M; Allegri F; Riccieri V; Alpini C; Gabrielli A; Tampoia M; Gerli R;
    Autoimmun Rev; 2012 Sep; 11(11):815-20. PubMed ID: 22394488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.